Approach to design push-pull osmotic pumps

International Journal of Pharmaceutics

Volumn 376, Issue 1-2, 2009, Pages 56-62

  Malaterre, Vincent ^a,b   Ogorka, Joerg ^a   Loggia, Nicoletta ^a   Gurny, Robert ^b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Controlled drug delivery; Oral osmotic pump; Push pull osmotic pumps

Indexed keywords

CHLORPHENIRAMINE MALEATE; ISRADIPINE; MACROGOL 400; OSMOTIC AGENT;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DETERMINATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STRUCTURE; MATHEMATICAL MODEL; OSMOTIC PUMP; PREDICTION; PRIORITY JOURNAL; PUSH PULL OSMOTIC PUMP; STRUCTURE ANALYSIS; TABLET FORMULATION; TABLET POROSITY; TABLET THICKNESS;

CHLORPHENIRAMINE; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; ISRADIPINE; MODELS, STATISTICAL; OSMOSIS; POLYETHYLENE GLYCOLS; TABLETS;

EID: 67349279801     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.04.015     Document Type: Article

References (32)

1. Abrahamsson B., Alpsten M., Bake B., Jonsson U.E., Eriksson-Lepkowska M., and Larsson A. Drug absorption from nifedipine hydrophilic matrix extended-release (ER) tablet-comparison with an osmotic pump tablet and effect of food. J. Controlled Release 52 (1998) 301-310
2. Anderson J.L., and Malone D.M. Mechanism of osmotic flow in porous membranes. Biophys. J. 14 (1974) 957-982
3. Assanasen P., and Naclerio R.M. Antiallergic anti-inflammatory effects of H1-antihistamines in humans. Clin. Allergy Immunol. 17 (2002) 101-139
4. Bansal A., Wanchoo R.K., and Sharma S.K. Dynamic liquid saturation in a trickle bed reactor involving newtonian/non-newtonian liquid phase. Ind. Eng. Chem. Res. 48 (2009) 3341-3350
5. Bindschaedler C., Gurny R., and Doelker E. Osmotic water transport through cellulose acetate membranes produced from a latex system. J. Pharm. Sci. 76 (1987) 455-460
6. Fitton A., and Benfield P. Isradipine-a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular-disease. Drugs 40 (1990) 31-74
7. Grundy J.S., and Foster R.T. The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties. Clin. Pharmacokinet. 30 (1996) 28-51
8. Guo J.H. Effects of plasticizers on water permeation and mechanical-properties of cellulose-acetate-antiplasticization in slightly plasticized polymer film. Dr. Dev. Ind. Pharm. 19 (1993) 1541-1555
9. Liu L.X., Khang G., Rhee J.M., and Lee H.B. Sandwiched osmotic tablet core for nifedipine controlled delivery. Bio-Med. Mat. Eng. 9 (1999) 297-310
10. Liu L.X., Ku J., Khang G., Lee B., Rhee J.M., and Lee H.B. Nifedipine controlled delivery by sandwiched osmotic tablet system. J. Controlled Release 68 (2000) 145-156
11. Lu E., Jiang Z.Q., Zhang Q.Z., and Jiang X.G. A water-insoluble drug monolithic osmotic tablet system utilizing gum arabic as an osmotic, suspending and expanding agent. J. Controlled Release 92 (2003) 375-382
12. Malaterre V., Metz H., Mäder K., Gurny R., and Loggia N. Influence of the hydration kinetics and the viscosity balance on the drug release performance of push-pull osmotic systems. 35th CRS Annual Meeting (2008)
13. Malaterre V., Metz H., Ogorka J., Gurny R., Loggia N., and Mäder K. Benchtop-magnetic resonance imaging characterization on the water-insoluble drug release from push-pull osmotic systems. J. Controlled Release 133 (2009) 31-36
14. Malaterre V., Ogorka J., Gurny R., and Loggia N. Evaluation of the tablet core factors influencing the release kinetics and the loadability of push-pull osmotic systems. Dr. Dev. Ind. Pharm. 35 4 (2009) 433-439
15. Moore J.W., and Flanner H.H. Mathematical comparison of dissolution profiles. Pharm. Tech. 20 (2008) 64-74
16. Pillay V., and Fassihi R. Evaluation and comparison of dissolution data derived from different modified release dosage forms: an alternative method. J. Controlled Release 55 (1998) 45-55
17. Rahima-Maoz C., Grossman E., Nussinovitch N., Katz A., and Rosenthal T. Nifedipine GITS replacing nifedipine SR: ambulatory blood pressure assessment of efficacy. Cardiology 88 (1997) 43-46
18. Rani M., and Mishra B. Comparative in vitro and in vivo evaluation of matrix, osmotic matrix, and osmotic pump tablets for controlled delivery of diclofenac sodium. PharmSci 4 (2004) 5
19. Rinaki E., Dokoumetzidis A., and Macheras P. The mean dissolution time depends on the dose/solubility ratio. Pharm. Res. 20 (2003) 406-408
20. Rumore M.M. Clinical pharmacokinetics of chlorpheniramine. Drug Intel. Clin. Pharm. 18 (1984) 701-707
21. Shah V.P., Tsong Y., Sathe P., and Liu J.P. In vitro dissolution profile comparison-statistics and analysis of the similarity factor, f(2). Pharm. Res. 15 (1998) 889-896
22. Smith M.B.H., and Feldman W. Over-the-counter cold medications-a critical-review of clinical-trials between 1950 and 1991. J. Am. Med. Assoc. 269 (1993) 2258-2263
23. Theeuwes F. Elementary osmotic pump. J. Pharm. Sci. 64 (1975) 1987-1991
24. Theeuwes F. Evolution and design of rate controlled osmotic forms. Curr. Med. Res. Opin. 8 (1983) 20-27
25. Theeuwes F. Oros osmotic system-development. Dr. Dev. Ind. Pharm. 9 (1983) 1331-1357
26. Theeuwes F. Oral dosage form design-status and goals of oral osmotic systems technology. Pharm. Int. 5 (1984) 293-296
27. Theeuwes F., and Yum S.I. Principles of design and operation of generic osmotic pumps for delivery of semisolid or liquid drug formulations. Ann. Biomed. Eng. 4 (1976) 343-353
28. Thombre A.G., Appel L.E., Chidlaw M.B., Daugherity P.D., Dumont F., Evans L.A.F., and Sutton S.C. Osmotic drug delivery using swellable-core technology. J. Controlled Release 94 (2004) 75-89
29. Thombre A.G., Zentner G.M., and Himmelstein K.J. Mechanism of water transport in controlled porosity osmotic devices. J. Membr. Sci. 40 (1989) 279-310
30. US Pharmacopeia XXXI, 2006. Chlorpheniramine extended-release and isradipine capsule monographs. US Pharmacopeial Convention, 1740 & 2482.
31. Verma R.K., Mishra B., and Garg S. Osmotically controlled oral drug delivery. Dr. Dev. Ind. Pharm. 26 (2000) 695-708
32. Wonnemann M., Schug B., Schmucker K., Brendel E., van Zwieten P.A., and Blumel H. Significant food interactions observed with a nifedipine modified-release formulation marketed in the European Union. Int. J. Clin. Pharm. Ther. 44 (2006) 38-48